Literature DB >> 7694642

Distribution of cAMP in secondary follicles and its expression in B cell apoptosis and CD40-mediated survival.

K A Knox1, G D Johnson, J Gordon.   

Abstract

Apoptosis occurs at a high rate among B cells in germinal centres (GCs). Isolated GC B cells undergo apoptosis spontaneously when cultured in vitro: such self-destruction can be arrested by protein kinase C-activating phorbol esters and by ligating surface CD40. This study sought to explore whether the cAMP-dependent second messenger system played a role in the regulation of GC cell apoptosis and in ligand-promoted survival. First, the distribution of cAMP in GCs was analysed by immunofluorescence staining and confocal laser scanning microscopy in situ: cytoplasmic cAMP was expressed by all cells but was most abundant in the constitutive cells of the light zones, where GC B cell apoptosis and rescue occur. Isolated GC B cells were found to express higher levels of cAMP than quiescent B lymphocytes as assessed both by a competitive binding assay and a newly developed flow cytometric method. Culturing GC B cells alone increased cAMP level, while those cells rescued with the phorbol ester phorbol myristate acetate (PMA) and anti-CD40 exhibited decreased cAMP levels. Resting B lymphocytes showed no change in cAMP level following culture alone, but a significant increase in cAMP levels when co-cultured with PMA and anti-CD40. These data suggest that given identical signals, resting B cells and GC B cells exhibit differential regulation of the cAMP-dependent second messenger system; moreover, this second messenger system appears to be involved in the regulation of apoptosis in GC B cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694642     DOI: 10.1093/intimm/5.9.1085

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  4 in total

1.  Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.

Authors:  Michael R Green; Stefano Monti; Riccardo Dalla-Favera; Laura Pasqualucci; Nicole C Walsh; Marc Schmidt-Supprian; Jeffery L Kutok; Scott J Rodig; Donna S Neuberg; Klaus Rajewsky; Todd R Golub; Frederick W Alt; Margaret A Shipp; John P Manis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases.

Authors:  M Wahle; S Kölker; A Krause; G R Burmester; C G Baerwald
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

3.  Differential expression of Ca(2+)-binding proteins on follicular dendritic cells in non-neoplastic and neoplastic lymphoid follicles.

Authors:  T Tsunoda; M Yamakawa; T Takahashi
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.

Authors:  R Fåhraeus; L Palmqvist; A Nerdstedt; S Farzad; L Rymo; S Laín
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.